Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow protection

M Guigon1, F Lemoine, A Najman

  • 1Department of Hematology, Hospital St. Antoine, Paris, France.

Bone Marrow Transplantation
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Protecting hematopoietic stem cells is crucial for preventing lethal aplasia during cancer treatment. Research explores various methods like gene therapy and chemical compounds to reduce chemotherapy and radiotherapy-induced myelotoxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative factors associated with donor twin demise in 1602 pregnancies complicated by twin-twin transfusion syndrome.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Molecular dynamics simulation of thermal transport across a solid/liquid interface created by a meniscus.

Physical chemistry chemical physics : PCCP·2023
Same author

Deep learning from phylogenies to uncover the epidemiological dynamics of outbreaks.

Nature communications·2022
Same author

Renewing Felsenstein's phylogenetic bootstrap in the era of big data.

Nature·2018
Same author

Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.

Allergy·2015
Same author

[Epidemiological characteristics of malaria in the village of Corail, Grand'Anse, Haiti].

Bulletin de la Societe de pathologie exotique (1990)·2014
Same journal

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

Bone marrow transplantation·2026
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Myelotoxicity from chemotherapy and radiotherapy limits effective cancer treatment doses.
  • Protecting hematopoietic stem cells is vital for restoring hematopoiesis and preventing aplasia.

Framework:

  • Discussed strategies for mitigating chemo- and radiotherapy-induced myelotoxicity.
  • Explored the role of bone marrow protection in cancer therapy.

Implementation:

  • Evaluated multi-drug resistance (MDR) gene therapy.
  • Examined chemical compounds (AS101, WR 2721).
  • Considered cytokines like TNF alpha and IL-1.
  • Assessed small peptides (pEEDCK, AcSKDP).

Implications:

Related Experiment Videos

  • Several agents show promise for protecting normal stem cells during marrow purging for autologous transplantation.
  • Potential to improve patient outcomes by enabling higher therapeutic doses.
  • Highlights the importance of supportive care in oncology.